Nuclear receptor coregulators as a new paradigm for therapeutic targeting
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The complex function and regulation of nuclear receptors cannot be fully understood without a thorough knowledge of the receptor-associated coregulators that either enhance (coactivators) or inhibit (corepressors) transcription. While nuclear receptors themselves have garnered much attention as therapeutic targets, the clinical and etiological relevance of the coregulators to human diseases is increasingly recognized. Aberrant expression or function of coactivators and corepressors has been associated with malignant and metabolic disease development. Many of them are key epigenetic regulators and utilize enzymatic activities to modify chromatin through histone acetylation/deacetylation, histone methylation/demethylation or chromatin remodeling. In this review, we showcase and evaluate coregulators with the most promising therapeutic potential based on their physiological roles and involvement in various diseases that are revealed thus far. We also describe the structural features of the coactivator and corepressor functional domains and highlight areas that can be further explored for molecular targeting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546 · cited 1×
“By coactivating PPAR-α and ERR-α, PGC-1α regulates several genes involved in mitochondrial biogenesis, respiration and fatty acid oxidation in cardiac and skeletal muscle [57-58], which likely explains its important role in maintaining normal oxidative capacity and energy metabolism in these tissues [59-61].”
BackgroundThe development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326 · cited 5×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript MAPK phosphorylation of SRC-1 and TIF2 at specific residues, for example, is required for optimal androgen-independent activation of AR by IL-6 and EGF [30-32].”
BackgroundInfluentialThe coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233 · cited 2×
“The counterparts of coactivators, called corepressors, were identified as mediators for selectively repressing NR-dependent gene transcription through interaction with unliganded or antagonist-bound (or in some cases, agonist-bound) NRs on their target genes [1].”
BackgroundPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821 · cited 3×
“Liver-specific expression of PGC-1α transgene increased blood glucose and insulin levels in normal non-fasting animals [62], while PGC-1 deficiency in the liver enhanced insulin sensitivity [68].”
BackgroundCellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708 · cited 1×
“Mounting evidence suggests that dynamic multi-level changes in chromatin structure that are mediated by transcriptional coregulators strongly impact cellular processes including differentiation, cell death, inflammation, and oncogenesis [76-79].”
BackgroundVega, R. B., Huss, J. M., & Kelly, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1868-1876.2000 · Cited by 1,195
Leone, T. C., Lehman, J. J., Finck, B. N., Schaeffer, P. J., Wende, A. R., Boudina, S., Courtois, M., Wozniak, D. F., Sambandam, N., Bernal-Mizrachi, C., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030101 · Cited by 951
Michael, L. F., Wu, Z., Cheatham, R. B., Puigserver, P., Adelmant, G., Lehman, J. J., Kelly, D. P., & Spiegelman, B. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061035098 · Cited by 663 · cited 1×
“In skeletal muscle, a key site for insulin action in vivo, PGC-1α induces expression of the insulin-sensitive glucose transporter GLUT4 and enhances glucose uptake through coactivation of the muscleselective transcription factor MEF2C [63].”
Background
Cited by
Thyroid Hormone Regulation of Metabolism
Mullur, R., Liu, Y.-Y., & Brent, G. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00030.2013 · Cited by 2,421
Mechanisms of thyroid hormone action
Brent, G. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60047 · Cited by 1,244
“interaction of TR with corepressors has been carefully mapped and tested (76, 77).”
Hu, M., Luo, Q., Alitongbieke, G., Chong, S., Xu, C., Xie, L., Chen, X., Zhang, D., Zhou, Y., Wang, Z., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.03.008 · Cited by 318
Self-citationNuclear receptor coregulators: modulators of pathology and therapeutic targets
Lonard, D. M., & O'Malley, B. W. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.100 · Cited by 272
Osz, J., Brélivet, Y., Peluso-Iltis, C., Cura, V., Eiler, S., Ruff, M., Bourguet, W., Rochel, N., & Moras, D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118192109 · Cited by 84
Metadata
- Authors
- Hsia, E. Y., Goodson, M. L., Zou, J. X., Privalsky, M. L., & Chen, H.-W.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 62
- Issue
- 13
- Pages
- 1227-1237
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1978300586
- Cited by
- 67
- References
- 20
- FWCI
- 0.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nuclear receptor coregulators as a new paradigm for therapeutic targeting. https://app.cochat.ai/papers/10.1016/j.addr.2010.09.016
- The paper
- Hsia, E. Y., Goodson, M. L., Zou, J. X., Privalsky, M. L., & Chen, H.-W. (2010). Nuclear receptor coregulators as a new paradigm for therapeutic targeting. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2010.09.016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.